Literature DB >> 11957024

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

M E Jiménez-Mejías1, C Pichardo-Guerrero, F J Márquez-Rivas, D Martín-Lozano, T Prados, J Pachón.   

Abstract

Described here is a case of meningitis caused by multidrug-resistant Acinetobacter baumannii susceptible only to colistin, which was treated successfully with intravenous colistin sulfomethate sodium (5 mg/kg/day). The levels of colistin in serum and cerebrospinal fluid and the pharmacokinetic/pharmacodynamic parameters of colistin were determined. In this case, intravenously administered colistin penetrated cerebrospinal fluid (25% of serum levels) at levels sustaining bactericidal concentrations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11957024     DOI: 10.1007/s10096-001-0680-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate.

Authors:  Roberto Imberti; Maria Cusato; Giovanni Accetta; Valeria Marinò; Francesco Procaccio; Alfredo Del Gaudio; Giorgio A Iotti; Mario Regazzi
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

2.  Serum and cerebrospinal fluid levels of colistin in pediatric patients.

Authors:  Charalampos Antachopoulos; Matti Karvanen; Elias Iosifidis; Britt Jansson; Diamantis Plachouras; Otto Cars; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

3.  Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.

Authors:  L A Arroyo; A García-Curiel; M E Pachón-Ibañez; A C Llanos; M Ruiz; J Pachón; J Aznar
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

4.  Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.

Authors:  Aspasia Katragkou; Emmanuel Roilides
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 5.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Identification of a polymyxin synthetase gene cluster of Paenibacillus polymyxa and heterologous expression of the gene in Bacillus subtilis.

Authors:  Soo-Keun Choi; Soo-Young Park; Rumi Kim; Seong-Bin Kim; Choong-Hwan Lee; Jihyun F Kim; Seung-Hwan Park
Journal:  J Bacteriol       Date:  2009-03-20       Impact factor: 3.490

7.  Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis.

Authors:  H Ozdemir; A Tapisiz; E Ciftçi; E Ince; H Mokhtari; H Güriz; A D Aysev; U Doğru
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

Review 8.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.

Authors:  O Bargiacchi; A Rossati; P Car; D Brustia; R Brondolo; F Rosa; P L Garavelli; F G De Rosa
Journal:  Infection       Date:  2014-04-12       Impact factor: 3.553

Review 9.  Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?

Authors:  Nilesh Kumta; Jason A Roberts; Jeffrey Lipman; Menino Osbert Cotta
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

10.  Penetration of colistin into cerebrospinal fluid.

Authors:  S L Markantonis; N Markou; M Fousteri; N Sakellaridis; S Karatzas; I Alamanos; E Dimopoulou; G Baltopoulos
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.